Mechanisms of Antifungal Resistance in Candida Species: Current Challenges and Future Directions
Keywords:
Candida, Antifungal resistance, Biofilm formation, Intrinsic resistance, Acquired resistance, Therapeutic developmentAbstract
Candida species are significant human pathogens responsible for various infections, particularly in immunocompromised individuals. The rise of antifungal resistance among these species poses serious challenges for treatment, complicating patient management and leading to increased morbidity and mortality. This review explores the mechanisms of antifungal resistance in Candida, including intrinsic and acquired resistance mechanisms, biofilm formation, and metabolic adaptations. Furthermore, we discuss the current challenges in managing antifungal resistance, including epidemiological trends, clinical implications, and limitations of existing antifungal agents. We also highlight future directions in research and therapeutic development, focusing on novel antifungal agents, combination therapies, and innovative approaches targeting biofilm-associated resistance. Understanding these mechanisms and challenges is essential for developing effective strategies to combat antifungal resistance and improve patient outcomes.
, , , , ,
References
1. Arendrup MC, Patterson TF. (2017). Multidrug-resistant Candida auris: a global threat to patients and health care systems. Emerg Infect Dis. 23(2):178-180. doi:10.3201/eid2302.161570.
2. Lockhart SR, Etienne KA, Kauffman CA, et al. (2017). Candida auris: An Emerging Fungal Pathogen. Clin Microbiol Rev. 30(1):1-18. doi:10.1128/CMR.00074-16.
3. Perlin DS. (2015). Antifungal drug resistance in Candida albicans and Candida glabrata. Curr Opin Microbiol. 30:105-111. doi:10.1016/j.mib.2016.06.005.
4. McManus BA, O'Donoghue E, McCarthy P, et al. (2017). The role of biofilm formation in the antifungal resistance of Candida species. Mycoses. 60(5):371-377. doi:10.1111/myc.12617.
5. Scherer L, Cerny M, Müller M, et al. (2021). Advances in understanding antifungal resistance mechanisms in Candida species. Med Mycol. 59(7):601-609. doi:10.1093/mmy/myab007.
6. Sanguinetti M, Posteraro B, Lass-Flörl C. (2015). Antifungal drug resistance among Candida species: mechanisms and clinical implications. Future Microbiol. 10(5):669-684. doi:10.2217/fmb.15.7.
7. Chen Y, et al. Mechanisms of azole resistance in Candida glabrata. Antimicrob Agents Chemother. 2016;60(5):3240-3247. doi:10.1128/AAC.02460-15.
8. Kaur R, et al. (2018). Role of ERG11 mutations in azole resistance in Candida albicans. J Med Microbiol. 67(2):130-138. doi:10.1099/jmm.0.000756.
9. Garcia-Effron G, et al. (2008). The role of FKS mutations in echinocandin resistance in Candida albicans. Antimicrob Agents Chemother. 52(6):2358-2360. doi:10.1128/AAC.00012-08.
10. Borman AM, et al. (2017). Role of efflux pumps in antifungal resistance of Candida species. Med Mycol. 55(8):749-759. doi:10.1093/mmy/myx044.
11. Chandra J, et al. (2001). Biofilm formation by Candida albicans: a microcolony model. Antimicrob Agents Chemother. 45(8):2528-2534. doi:10.1128/AAC.45.8.2528-2534.2001.
12. Cormack BP, et al. (2006). Metabolic adaptation of Candida albicans during antifungal therapy. Eukaryot Cell. 5(4):663-674. doi:10.1128/EC.00030-06.
13. Lockhart SR, et al. (2017). Candida auris: An Emerging Fungal Pathogen. Clin Microbiol Rev. 30(1):1-18. doi:10.1128/CMR.00074-16.
14. Perlin DS. (2015). Antifungal drug resistance in Candida albicans and Candida glabrata. Curr Opin Microbiol. 30:105-111. doi:10.1016/j.mib.2016.06.005.
15. Sanguinetti M, et al. (2015). Antifungal resistance among Candida species: mechanisms and clinical implications. Future Microbiol. 10(5):669-684. doi:10.2217/fmb.15.7.
16. Arendrup MC, et al. (2016). The role of novel antifungal agents in the treatment of fungal infections. J Antimicrob Chemother. 71(4):914-927. doi:10.1093/jac/dkv380.
17. Shapiro RS, et al. (2016). Combination antifungal therapy: where do we stand? Future Microbiol. 11:857-870. doi:10.2217/fmb-2016-0046.
18. Ghosh A, et al. (2018). Innovative strategies for biofilm eradication in fungal infections. Mycopathologia. 183(3):557-564. doi:10.1007/s11046-018-0297-6.
19. Koo H, et al. (2017). The promise of genomics and proteomics in understanding antifungal resistance. J Microbiol. 55(1):1-8. doi:10.1007/s12275-017-6388-1.
